← All companies

BFRI

Biofrontera Inc.

BFRIW Nasdaq Pharmaceutical Preparations EDGAR ↗

$0.03

-0.00 -10.00%

Key statistics

from XBRL data in SEC filings

Market cap

$346K

Revenue (TTM)

$43.2M

Net income (TTM)

-$11.1M

EPS (TTM)

$-0.98

P/E ratio

—

Dividend yield

—

Free cash flow

-$13.4M

Cash

$6.32M

Total assets

$24.8M

Gross margin

—

52-week range

$0.03 – $0.03

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-K/A Fiscal year ended 2025-12-31 Jul 22, 2026 8-K Shareholder vote results Jun 17, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Results of operations (earnings release) May 14, 2026 10-K Fiscal year ended 2025-12-31 Mar 19, 2026 8-K Results of operations (earnings release) Mar 19, 2026 8-K Regulation FD disclosure Mar 9, 2026 8-K Other events Feb 26, 2026 8-K Regulation FD disclosure Feb 9, 2026 8-K Results of operations (earnings release) Jan 13, 2026 8-K Delisting notice or listing-rule failure Jan 7, 2026 8-K Results of operations (earnings release) Nov 13, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Other events Nov 10, 2025 8-K Entered a material agreement; Completed an acquisition or disposition; Regulation FD disclosure Nov 7, 2025 8-K Entered a material agreement; Completed an acquisition or disposition; Unregistered sale of equity; Other events Oct 24, 2025 8-K Regulation FD disclosure Oct 23, 2025 8-K Shareholder vote results Sep 19, 2025 8-K Results of operations (earnings release) Aug 13, 2025 10-Q Quarter ended 2025-06-30 Aug 13, 2025 8-K Director or officer change; Regulation FD disclosure Aug 11, 2025 8-K/A Jul 16, 2025 8-K Entered a material agreement; Unregistered sale of equity; Modified rights of security holders; Amended charter or bylaws Jul 1, 2025 8-K Regulation FD disclosure Jun 30, 2025 8-K Shareholder vote results Jun 18, 2025 8-K Other events Jun 11, 2025 8-K Other events Jun 3, 2025 8-K Delisting notice or listing-rule failure May 23, 2025 8-K Results of operations (earnings release) May 15, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Delisting notice or listing-rule failure May 14, 2025 8-K Changed accountants Apr 18, 2025 8-K Results of operations (earnings release) Mar 21, 2025 10-K Fiscal year ended 2024-12-31 Mar 20, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Delisting notice or listing-rule failure Nov 27, 2024 8-K Regulation FD disclosure Nov 22, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Results of operations (earnings release) Nov 13, 2024 8-K Regulation FD disclosure Oct 31, 2024 8-K Regulation FD disclosure Oct 7, 2024